Posts

Showing posts from November, 2020

A cervical cancer-free future: First-ever global commitment to eliminate a cancer - World Health Organization

Image
A cervical cancer-free future: First-ever global commitment to eliminate a cancer - World Health Organization A cervical cancer-free future: First-ever global commitment to eliminate a cancer - World Health Organization Posted: 17 Nov 2020 12:00 AM PST WHO's Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050. Today's development represents a historic milestone because it marks the first time that 194 countries commit to eliminating cancer - following adoption of a resolution at this year's World Health Assembly.  Meeting the following targets by 2030 will place all countries on the path toward elimination: 90% of girls fully vaccinated with the HPV vaccine by 15 years of age 70% of women screened usi...

A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region. - Physician's Weekly

Image
A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region. - Physician's Weekly A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region. - Physician's Weekly Posted: 29 Nov 2020 09:18 PM PST Human papillomavirus (HPV) is a major cause of cervical cancer in women. The characteristics of HPV infection vary; therefore, it is necessary to identify the most common HPV genotypes among a group of subjects when introducing a vaccine program. Currently, in the Yanbian Autonomous Region, no HPV vaccinations are not provided, and no data has been reported regarding HPV rates or genotype prevalence. We aimed to find the most suitable HPV vaccine for this region and reasons why no vaccine has been introduced. HPV genotyping of 200 Korean-Chinese women living i...

Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier

Image
Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier Study aims to reduce HPV and COVID-19 vaccine hesitancy among teens in rural Alabama - The Mix A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region. - Physician's Weekly Impact of Covid-19 on Human Papillomavirus (HPV) Vaccines Market is to Witness Significant Growth between 2020-2026 with leading players – Merck, GSK, Walvax,, - The Courier Posted: 29 Nov 2020 09:58 AM PST " Up-To-Date research on Human Papillomavirus (HPV) Vaccines Market 2020-2025 : The R...

WHO releases new estimates of the global burden of cervical cancer associated with HIV - World Health Organization

Image
WHO releases new estimates of the global burden of cervical cancer associated with HIV - World Health Organization WHO releases new estimates of the global burden of cervical cancer associated with HIV - World Health Organization Posted: 16 Nov 2020 12:00 AM PST Today as WHO launches the Global Strategy to Accelerate the Elimination of Cervical Cancer , the first estimates of the contribution of HIV to the global cervical cancer burden are also being released.  Women living with HIV have a six-fold increased risk of cervical cancer when compared to women without HIV. This higher risk is manifested throughout the lifecycle starting with an increased risk of acquiring human papilloma virus infection (HPV), more rapid progression to cancer, lower chances of regression of pre-cancer lesions, higher rates of recurrence following treatment.   Worldwide, an estimated 5% of all cervical cancer cases are attributable to HIV. However, these statist...

Ask the Doctors: It's safe to proceed with HPV vaccinations during COVID-19 - Tulsa World

Image
Ask the Doctors: It's safe to proceed with HPV vaccinations during COVID-19 - Tulsa World Ask the Doctors: It's safe to proceed with HPV vaccinations during COVID-19 - Tulsa World Posted: 24 Nov 2020 10:00 PM PST {{featured_button_text}} Dear Doctors: My daughter is overdue for her second shot of the HPV vaccine, but I'm hesitant due to the pandemic because I want her immunity to be strong right now. Are you recommending people get this vaccine during COVID? Dear Reader: The short answer is yes, we strongly encourage everyone to receive all of their routine vaccinations at this time, including the series for the human papilloma virus, also known as HPV. Although vaccines work by interacting with the immune system, each one is specific to a certain infectious agent. The HPV vaccine creates antibodies to the human papilloma virus. That means it will not interfere with the immune system's ability ...

Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake - American Academy of Pediatrics

Image
Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake - American Academy of Pediatrics Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake - American Academy of Pediatrics Posted: 01 Nov 2020 12:00 AM PDT What's Known on This Subject: Human papillomavirus (HPV) vaccination offers substantial benefits for cancer prevention, yet uptake remains well below national targets. Although interventions to address low HPV vaccination coverage have been tested, the cost-effectiveness of these interventions over the long-term is unexplored. What This Study Adds: We find 3 interventions for increasing HPV vaccination are cost-effective at common thresholds compared with status quo. HPV vaccination interventions are a high-value use of state funding and could prevent from 3000 to 14 000 incident HPV cancers over the next 50 years. Human papillomavirus (HPV) infections cause 34 800 cancers annually in the Un...